Short Interest in Beyond Air, Inc. (NASDAQ:XAIR) Rises By 27.5%

Beyond Air, Inc. (NASDAQ:XAIR) saw a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 1,530,000 shares, a growth of 27.5% from the February 13th total of 1,200,000 shares. Based on an average trading volume of 1,550,000 shares, the days-to-cover ratio is presently 1.0 days. Currently, 2.8% of the shares of the company are sold short.

Beyond Air Trading Up 7.2 %

Shares of XAIR stock opened at $0.27 on Monday. The firm has a market capitalization of $18.48 million, a P/E ratio of -0.25 and a beta of 0.16. Beyond Air has a 1 year low of $0.24 and a 1 year high of $1.78. The firm’s fifty day simple moving average is $0.35 and its 200 day simple moving average is $0.41.

Beyond Air (NASDAQ:XAIR) last announced its quarterly earnings data on Monday, February 10th. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.09. Beyond Air had a negative net margin of 1,730.00% and a negative return on equity of 226.01%. During the same quarter last year, the company earned ($0.50) earnings per share. Equities research analysts anticipate that Beyond Air will post -0.79 EPS for the current fiscal year.

Institutional Trading of Beyond Air

A number of hedge funds have recently modified their holdings of the company. Squarepoint Ops LLC acquired a new position in shares of Beyond Air in the 4th quarter valued at $48,000. Wealthedge Investment Advisors LLC acquired a new position in Beyond Air in the fourth quarter worth about $80,000. Baldwin Wealth Partners LLC MA lifted its stake in Beyond Air by 721.3% during the fourth quarter. Baldwin Wealth Partners LLC MA now owns 308,000 shares of the company’s stock worth $110,000 after purchasing an additional 270,500 shares during the period. Geode Capital Management LLC boosted its holdings in Beyond Air by 81.0% during the fourth quarter. Geode Capital Management LLC now owns 562,713 shares of the company’s stock valued at $202,000 after purchasing an additional 251,823 shares in the last quarter. Finally, Soros Fund Management LLC bought a new stake in shares of Beyond Air in the 3rd quarter valued at approximately $573,000. Institutional investors own 31.50% of the company’s stock.

About Beyond Air

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.